Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.

Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....

Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

Text size Axsome is reviewing the proposed labeling from the FDA. Dreamstime Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attemp...

Roku, Tesla, and Other Cathie Wood Favorites Are Falling

Text size Ark Invest CEO Cathie Wood. Courtesy of ARK Cathie Wood’s $12 billion flagship exchange-traded fund was falling again in Monday trading. It is another sign that “innovation stocks” such as R...

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...

Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...

Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup

OMAHA, Neb. — Warren Buffett’s company on Monday revealed all the investment moves it made in the first quarter, when it spent more than $51 billion on stocks. But Buffett had already shared the bigge...

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...

Disney, Occidental, Rivian, Palantir, BioNTech, and Other Stocks to Watch This Week

Text size We’re past the peak of first-quarter earnings season, but with several notable companies still left to report next week. The economic-data highlights of the week will be a pair of inflation ...

Disney, Occidental, Rivian, Palantir, BioNTech, and Other Stocks for Investors to Watch This Week

Text size We’re past the peak of first-quarter earnings season, but with several notable companies still left to report next week. The economic-data highlights of the week will be a pair of inflation ...

AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key dru...

Stocks for the Recession That May—or May Not—Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s...

Alibaba and Other Chinese Stocks Got Crushed Thursday. Here’s Why.

Text size Chinese stocks including Alibaba fell on concerns they would eventually be delisted in the U.S. Qilai Shen/Bloomberg Alibaba (BABA), Yum China Holdings (YUMC), ACM Research (ACMR), Baidu (BI...

Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver

Viatris Inc. said Monday it has agreed to combine its biosimilars portfolio with privately held Indian company Biocon Biologics Ltd. for up to $3.335 billion, as part of a broader overhaul of its busi...

Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.

Viatris will sell the biosimilars business of the former Mylan to the Indian drugmaker Biocon for as much as $3.3 billion. Dreamstime Text size Viatris , the company formed in 2020 through a merger of...